medigraphic.com

2013, Number 1

<< Back

Rev Med Inst Mex Seguro Soc 2013; 51 (1)

Practice guideline. Diagnosis and treatment of type 2 diabetes mellitus

Gil-Velázquez LE, Sil-Acosta MJ, Domínguez-Sánchez ER, Torres-Arreola LP, Medina-Chávez JH

Language: Spanish
References: 34
Page: 104-119
PDF size: 130.99 Kb.


ABSTRACT

Our objective was to develop a guide based on the best available evidence that allow family physicians to establish criteria for screening, diagnosis, prevention, treatment of disease, early detection and management of complications; to standardize the organizing processes of the diabetic patient’s care in the primary care level; and to achieve lifestyle modification for patients and promote self-care. Clinical questions were stated according to the diagram and structured patient-intervention-comparison-outcome. We used a mixed methodology-adoption adjustment, and include 32 guides. For recommendations not included in these, the search process was conducted in PubMed and Cochrane Library Plus with these terms: diabetes mellitus type 2, epidemiology, detection and diagnosis, classification, drug therapy, effects, prevention, control and complication. The clinical practice guideline emphasizes the fundamental change in lifestyle (diet and exercise), self-care and proactive participation of the patient, in addition to the dynamic prescription of medications that would achieve metabolic control in order to reduce late complications.


REFERENCES

  1. Psaltopoulou T, Ilias I, Alevizaki M. The role of diet and lifestyle in primary, secondary, and tertiary diabetes prevention: a review of meta-analyses. Rev Diabet Stud. 2010;7(1):26-35.

  2. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;(5):1047-53.

  3. Organización Panamericana de la Salud. Estrategia regional y plan de acción para un enfoque integrado. Sobre la prevención y el control de las enfermedades crónicas. Washington, DC: OPS; 2007.

  4. Perdigón-Villaseñor G, Fernández-Cantón S. Recent evolution of the behavior of diabetes mellitus in Mexico during childhood and adolescence (1990- 2007). Bol Med Hosp Infant Mex. 2009;66:293-6.

  5. Méndez-Durán A, Méndez-Bueno JF, Tapia-Yáñez T, Muñoz-Montes A, Aguilar-Sánchez L. Epidemiología de la insufi ciencia renal en México. Dial Traspl. 2010;31(1):7-11.

  6. Gutiérrez-Trujillo G, Flores-Huerta S, Fernández- Gárate I, Martínez-Montañez O, Velasco-Murillo V, Fernández-Cantón S, et al. Estrategia de prestación y evaluación de servicios preventivos. Rev Med Inst Mex Seguro Soc. 2006;44(Supl 1):S3-S21.

  7. Instituto Mexicano del Seguro Social. Informe al Ejecutivo Federal y al Congreso de la Unión sobre la situación fi nanciera y los riesgos del Instituto Mexicano del Seguro Social 2009-2010. México: IMSS; 2010.

  8. Gerstein H, Santaguida P, Raina P, Morrison KM, Balion C, Hunt D, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies. Diab Res Clin Pract. 2007;78(3):305-12.

  9. Ministerio de Sanidad y Consumo. Guía de práctica clínica sobre diabetes tipo 2. España: Ministerio de Sanidad y Consumo; 2008.

  10. Handelsman Y, Mechanick JI, Blonde L, Grunberger G, Bloomgarden ZT, Bray GA, et al. American Association of Clinical Endocrinologists. Medical Guidelines for clinical practice for developing a diabetes mellitus comprehensive care plan: executive summary. Endocr Pract. 2011;17(2):287-302.

  11. Canadian Diabetes Association. Clinical practice guidelines for the prevention and management of diabetes in Canada. 2008. Can J Diabetes 2008;32(Suppl. 1). Disponible en http://www.diabetes. ca/fi les/cpg2008/cpg-2008.pdf

  12. American Diabetes Association. Diabetes Basics. Type 2. Disponible en http://www.diabetes.org/ diabetes-basics/type-2/?loc=404

  13. Kattah W, Coral P, Méndez F. Evaluación del impacto de un programa de tratamiento y educación en la reducción de los niveles de hemoglobina glucosilada en los pacientes con diagnóstico de diabetes. Acta Med Colom. 2007;32(4):206-11.

  14. Golberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BJ. Exercise and type 2 diabetes. The American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010;33(12):e147-67.

  15. Asociación Latinoamericana de Diabetes. Guías ALAD de diagnóstico, control y tratamiento de la diabetes mellitus tipo 2. Organización Panamericana de la Salud/ALAD; 2008. Disponible en http:// www.paho.org/spanish/ad/dpc/nc/dia-guia-alad.pdf

  16. The National Collaborating Centre for Chronic Conditions. Chronic Kidney Disease. National clinical guideline for early identifi cation and management in adults in primary and secondary care. London, UK: Royal College of Physicians; 2008.

  17. California Healthcare Foundation/American Geriatrics Society Panel on Improving Care for Elders with Diabetes. Guidelines for improving the care of the older person with diabetes mellitus. JAGS. 2003;51:S265-80.

  18. Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, et al.; Canadian Society of Nephrology (CSN). Guidelines for the management of chronic kidney disease. CMAJ. 2008;179(11): 1154-62.

  19. UK Prospective Diabetes Study Group (UKPDS). Intensive blood-glucose control with sulfonilureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. (UKPDS 33). Lancet. 1998;352(9131):837-52.

  20. Nathan DM. Initial management of glycemia in type 2 diabetes mellitus. N Engl J Med. 2002;347:1342-9.

  21. American Diabetes Association. Standars of Medical Care in Diabetes-2011. Diabetes Care. 2011;34 (Suppl 1):S11-61.

  22. Guía de práctica clínica. Detección y estratifi cación de factores de riesgo cardiovascular. México: IMSS; 2010.

  23. Greenland P, Alpert JS, Beller GA, Benjamin EJ, Budoff MJ, Fayad ZA, et al. ACCF/AHA guideline for assessment of cardiovascular risk in asymmptomatic adults. J Am Coll Cardiol. 2010;56:e50-103.

  24. Caja Costarricense de Seguro Social. Tratamiento de diabetes tipo 2. Costa Rica: Caja Costarricense de Seguro Social; 2005.

  25. Ministerio de Salud. Guía clínica 2010. Diabetes mellitus tipo 2. Santiago de Chile: Minsal; 2010.

  26. Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M, Knowler WC, et al. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol. 1996;(67)(10 Suppl);1085-93.

  27. Mealey BL. Periodontal disease and diabetes: a two-way street. J Am Dent Assoc. 2006;137(10 Suppl):26S-31S.

  28. Caja Costarricense del Seguro Social. [Sitio web]. Sección Publicaciones. Guía para la atención de las personas diabéticas tipo 2. Costa Rica: Caja Costarricense del Seguro Social; 2007.

  29. Ezkurra-Loiola P, editor. Práctica clínica en la DM2. Análisis crítico de las evidencias por la RedGDPS. España: Elsevier; 2011.

  30. Instituto Mexicano del Seguro Social. Guía de práctica clínica, diagnóstico y tratamiento de la enfermedad arterial periférica. México: IMSS; 2008.

  31. Bacon CG, Hu FB, Giovannucci E, Glasser DB, Mittleman MA, Rimm EB. Association of type and duration of diabetes with erectile dysfunction in a large cohort of men. Diabetes Care. 2002;25(8):1458-63.

  32. Instituto Mexicano del Seguro Social. Guía de práctica clínica, prevención, diagnóstico y tratamiento de la enfermedad renal crónica temprana. México: IMSS; 2009.

  33. Brenner BM. Retarding the progression of renal disease. Kidney Int. 2003;64(1):370-8.

  34. Kidney Disease Outcomes Quality Iniciative (KDQI) 2007. Clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease. Am J Kidney Dis. 2007;49 (Suppl 2):S1-S160.




2020     |     www.medigraphic.com